Aurora, Colorado
Phase 1 cancer trials in Aurora, CO
56 Phase 1 cancer studies are recruiting participants at sites in Aurora as of November 17, 2026, according to ClinicalTrials.gov. Phase 1 Cancer Trials can help you understand your options and connect with a study team.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Aurora at a glance
- 56 studies are recruiting at a site in Aurora.
- By phase: Phase 1 (23), Phase 1/2 (33).
- By sponsor: industry (44), university, hospital or other (12).
- By research area: Lymphoma (17), Lung Cancer (14), Breast Cancer (12), Pancreatic Cancer (6), Melanoma (4), Prostate Cancer (3).
- Most recent update to one of these records: November 17, 2026.
Breast cancer studies recruiting in Aurora
Basic details from each study's public record (the 30 most recently updated of 56). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
A Phase 1/2 Study of IAM1363 in HER2 Cancers
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Iambic Therapeutics, Inc
- Study site
- University of Colorado Cancer Center
- Registry record
- NCT06253871 · updated
Study of Patritumab Deruxtecan With Other Anticancer Agents in Participants With HER2 Positive Breast Cancer That Has Spread and Cannot Be Surgically Removed (MK-1022-009)
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Study site
- University of Colorado Anschutz Medical Campus ( Site 0057)
- Registry record
- NCT06686394 · updated
A Dose Randomization Study of Bulumtatug Fuvedotin in TNBC Patients Previously Treated With ADCs
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Mabwell (Shanghai) Bioscience Co., Ltd.
- Study site
- Anschutz Medical Center
- Registry record
- NCT06908928 · updated
A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Genentech, Inc.
- Study site
- University of Colorado Cancer Center
- Registry record
- NCT07100106 · updated
First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, as Monotherapy and in Combination With Anticancer Therapy in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Accent Therapeutics
- Study site
- University of Colorado Denver
- Registry record
- NCT06799065 · updated
Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Olema Oncology, Inc.
- Study site
- University of Colorado
- Registry record
- NCT06784193 · updated
Source: ClinicalTrials.gov. Data processed . See every breast cancer study recruiting in Aurora, CO on ClinicalTrials.gov.
Lung cancer studies recruiting in Aurora
A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
- Phase 1
- Ages 18 to 99
- All sexes
- Sponsor
- Erasca, Inc.
- Study site
- University of Colorado
- Registry record
- NCT06983743 · updated
Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- SystImmune Inc.
- Study site
- University of Colorado - Anschutz Cancer Pavilion
- Registry record
- NCT07080242 · updated
A Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People With Small Cell Lung Cancer (MK-6070-003)
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Study site
- University of Colorado, Anschutz Cancer Pavilion ( Site 0125)
- Registry record
- NCT07227597 · updated
A Phase 1/2 Study of TRI-611 in ALK-Positive NSCLC
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- TRIANA Biomedicines, Inc.
- Study site
- University of Colorado Cancer Center
- Registry record
- NCT07491497 · updated
Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- AbbVie
- Study site
- University Of Colorado - Anschutz Medical Campus /ID# 269069
- Registry record
- NCT06772623 · updated
Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Pfizer
- Study site
- Rocky Mountain Cancer Centers,LLP
- Registry record
- NCT07227298 · updated
A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002)
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Study site
- University of Colorado Anschutz Medical Campus ( Site 1110)
- Registry record
- NCT06780137 · updated
Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors
- Phase 1/2
- Ages 18 to 130
- All sexes
- Sponsor
- AstraZeneca
- Registry record
- NCT05797168 · updated
Source: ClinicalTrials.gov. Data processed . See every lung cancer study recruiting in Aurora, CO on ClinicalTrials.gov.
Prostate cancer studies recruiting in Aurora
A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer
- Phase 1
- Ages 18 and older
- Male participants
- Sponsor
- Janssen Research & Development, LLC
- Study site
- University of Colorado Anschutz Medical Campus
- Registry record
- NCT06095089 · updated
FOG-001 in Locally Advanced or Metastatic Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Parabilis Medicines, Inc.
- Study site
- University of Colorado
- Registry record
- NCT05919264 · updated
Source: ClinicalTrials.gov. Data processed . See every prostate cancer study recruiting in Aurora, CO on ClinicalTrials.gov.
Melanoma studies recruiting in Aurora
A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)
- Phase 1/2
- From 6 months, up to 17 years
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Study site
- Call for Information (Investigational Site 0019)
- Registry record
- NCT02332668 · updated
A First-in-human Study of RLY-8161 in Advanced NRAS-Mutant Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Relay Therapeutics, Inc.
- Study site
- University of Colorado Hospital
- Registry record
- NCT07584226 · updated
Source: ClinicalTrials.gov. Data processed . See every melanoma study recruiting in Aurora, CO on ClinicalTrials.gov.
Lymphoma studies recruiting in Aurora
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- Phase 1/2
- Up to age 22
- All sexes
- Sponsor
- PedAL BCU, LLC
- Study site
- Children's Hospital Colorado
- Registry record
- NCT04726241 · updated
Study of NX-5948 in Combination With Other Agents in Adults With B-cell Malignancies
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Nurix Therapeutics, Inc.
- Study site
- Rocky Mountain Cancer Centers
- Registry record
- NCT07520006 · updated
A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)
- Phase 1
- Ages 0 to 18
- All sexes
- Sponsor
- Autolus Limited
- Study site
- Children's Hospital Colorado
- Registry record
- NCT06173518 · updated
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
- Phase 1/2
- Ages 12 and older
- All sexes
- Sponsor
- Nuvalent Inc.
- Study site
- University of Colorado Cancer Center
- Registry record
- NCT05384626 · updated
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Eli Lilly and Company
- Study site
- University of Colorado Denver - School of Medicine - Anschutz Medical Campus
- Registry record
- NCT07101328 · updated
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
- Phase 1/2
- From 6 months, up to 25 years
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Study site
- Children's Hospital Colorado-Center for Cancer and Blood Disorders ( Site 1016)
- Registry record
- NCT06395103 · updated
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
- Phase 1/2
- From 30 days
- All sexes
- Sponsor
- Syndax Pharmaceuticals
- Study site
- University of Colorado
- Registry record
- NCT04065399 · updated
Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- SciTech Development, Inc.
- Study site
- University of Colorado Anschutz Medical Campus
- Registry record
- NCT04234048 · updated
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
- Phase 1/2
- Up to age 25
- All sexes
- Sponsor
- Turning Point Therapeutics, Inc.
- Study site
- Children's Hospital Colorado - Anschutz Medical Campus
- Registry record
- NCT04094610 · updated
Source: ClinicalTrials.gov. Data processed . See every lymphoma study recruiting in Aurora, CO on ClinicalTrials.gov.
Pancreatic cancer studies recruiting in Aurora
Intraperitoneal Paclitaxel With NALIRIFOX for Pancreatic Ductal Adenocarcinoma With Peritoneal Carcinomatosis
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- University of Colorado, Denver
- Study site
- University of Colorado Cancer Center
- Registry record
- NCT07030283 · updated
A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Study sites
- University of Colorado Anschutz Medical Campus ( Site 0299) · University of Colorado Anschutz Medical Campus ( Site 0325) · University of Colorado Anschutz Medical Campus ( Site 0326)
- Registry record
- NCT06428409 · updated
A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advanced Gastrointestinal Cancers That Cannot be Surgically Removed (EMBOLD PanGI-201)
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- GlaxoSmithKline
- Study site
- GSK Investigational Site
- Registry record
- NCT06885034 · updated
Source: ClinicalTrials.gov. Data processed . See every pancreatic cancer study recruiting in Aurora, CO on ClinicalTrials.gov.
Ask about studies near Aurora
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
More locations in Colorado
All Colorado locations
126 studies recruiting across 10 cities.
Denver
64 studies recruiting.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 17, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that are in Phase 1, including early Phase 1 and combined Phase 1/2, as each study is coded in the registry.
Phase 1 Cancer Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections